These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 955232)

  • 21. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW; Woodford R
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract]   [Full Text] [Related]  

  • 22. In vivo and in vitro percutaneous absorption of cancer preventive flavonoid apigenin in different vehicles in mouse skin.
    Li B; Birt DF
    Pharm Res; 1996 Nov; 13(11):1710-5. PubMed ID: 8956339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic effects and percutaneous absorption of topically applied 0.1% hydrocortisone 17-butyrate.
    Kukita A; Yamada K; Takeda Y
    Dermatologica; 1976; 152 Suppl 1():197-207. PubMed ID: 955235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous absorption of topical corticosteroids.
    Wester RC; Maibach HI
    Curr Probl Dermatol; 1993; 21():45-60. PubMed ID: 8299376
    [No Abstract]   [Full Text] [Related]  

  • 25. [Simultaneous determination of urea and hydrocortisone penetration into human skin].
    Wohlrab W
    Dermatol Monatsschr; 1990; 176(2-3):139-43. PubMed ID: 2365109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Urea in combination with corticosteroids in treating eczema].
    Drosner M
    Hautarzt; 1989; 40 Suppl 9():47-50. PubMed ID: 2681076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin.
    Barry BW; Bennett SL
    J Pharm Pharmacol; 1987 Jul; 39(7):535-46. PubMed ID: 2886623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Availability of active substances in and on the skin. Comparative study of the liberation and penetration of various cyproterone and cyproterone acetate ointments].
    Kotwas J; Schaefer H; Zesch A
    Arzneimittelforschung; 1979; 29(3):562-8. PubMed ID: 582747
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo and in vitro percutaneous absorption of [14C]pyrene in Sprague Dawley male rats: skin reservoir effect and consequence on urinary 1-OH pyrene excretion.
    Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Ferrari E
    Arch Toxicol; 2008 Oct; 82(10):739-47. PubMed ID: 18421439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excretion of 4-14C corticosteroids in urine by an ovariectomized bovine.
    Willett LB; Dunn TG; Brown BL; Erb RE
    J Anim Sci; 1971 Jan; 32(1):119-22. PubMed ID: 5546870
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of a noninvasive method for monitoring percutaneous absorption of lidocaine in vivo.
    Kushla GP; Zatz JL
    Pharm Res; 1990 Oct; 7(10):1033-7. PubMed ID: 2281032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human percutaneous penetration of hydrocortisone: the vulva.
    Britz MB; Maibach HI; Anjo DM
    Arch Dermatol Res; 1980; 267(3):313-6. PubMed ID: 7406539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sensitization to topical corticoids in patients with chronic eczema of the legs].
    Lazzarini S
    AMB Rev Assoc Med Bras; 1979 Apr; 25(4):118-20. PubMed ID: 315593
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of polyoxypropylene 15 stearyl ether and propylene glycol on percutaneous penetration rate of diflorasone diacetate.
    Turi JS; Danielson D; Woltersom JW
    J Pharm Sci; 1979 Mar; 68(3):275-80. PubMed ID: 423113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of topical dose and percutaneous absorption in rhesus monkey and man.
    Wester RC; Maibach HI
    J Invest Dermatol; 1976 Oct; 67(4):518-20. PubMed ID: 823268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Objective determination of the bioavailability of dermocorticoids--influence of the formulation.
    Poelman MC; Leveque JL; Le Gall F
    Br J Dermatol; 1984 Jul; 111 Suppl 27():158-62. PubMed ID: 6743548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring.
    van der Valk PG; Maibach HI
    J Am Acad Dermatol; 1989 Sep; 21(3 Pt 1):519-22. PubMed ID: 2778114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous absorption of corticosteroids: systemic effects.
    Scoggins RB; Kliman B
    N Engl J Med; 1965 Oct; 273(16):831-40. PubMed ID: 5825903
    [No Abstract]   [Full Text] [Related]  

  • 39. Penetration of various corticosteroids through epidermis in vitro.
    Ponec M; Polano MK
    Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational use of topical corticosteroids.
    Sherertz EF; Flowers FP
    Am Fam Physician; 1984 Jan; 29(1):262-6. PubMed ID: 6695652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.